Wnt signaling stabilizes the DIXDC1 protein through decreased ubiquitin-dependent degradation

Cancer Science

Volumn 101, Issue 3, 2010, Pages 700-706

  Wang, Lei ^a   Li, Hua ^a   Chen, Qi ^a   Zhu, Tengfang ^a   Zhu, Hongguang ^a   Zheng, Li ^b  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; DIX DOMAIN CONTAINING 1; MESSENGER RNA; UNCLASSIFIED DRUG; WNT PROTEIN; WNT3A PROTEIN;

ARTICLE; CANCER CELL; CELL PROLIFERATION; CLINICAL ARTICLE; COLON CANCER; COLON MUCOSA; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; REGULATORY MECHANISM; TISSUE DISTRIBUTION; UBIQUITINATION; UPREGULATION;

CYCLOHEXIMIDE; HELA CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICROFILAMENT PROTEINS; PHOSPHORYLATION; RNA, MESSENGER; SIGNAL TRANSDUCTION; UBIQUITIN; WNT PROTEINS;

EID: 77949599425     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01448.x     Document Type: Article

References (29)

1. Bienz M, Clevers H. Linking colorectal cancer to Wnt signaling. Cell 2000, 103:311-20.
2. Cadigan KM, Nusse R. Wnt signaling: a common theme in animal development. Genes Dev 1997, 11:3286-305.
3. Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature 2005, 434:843-50.
4. Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 2003, 1653:1-24.
5. Miller JR. The Wnts. Genome Biol 2002, 3:REVIEWS3001.
6. Wang X, Zheng L, Zeng Z. DIXDC1 isoform, l-DIXDC1, is a novel filamentous actin-binding protein. Biochem Biophys Res Commun 2006, 347:22-30.
7. Liu W, Dong X, Mai M. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat Genet 2000, 26:146-7.
8. Shiomi K, Kanemoto M, Keino-Masu K, Yoshida S, Soma K, Masu M. Identification and differential expression of multiple isoforms of mouse Coiled-coil-DIX1 (Ccd1), a positive regulator of Wnt signaling. Brain Res Mol Brain Res 2005, 135:169-80.
9. Shiomi K, Uchida H, Keino-Masu K, Masu M. Ccd1, a novel protein with a DIX domain, is a positive regulator in the Wnt signaling during zebrafish neural patterning. Curr Biol 2003, 13:73-7.
10. Soma K, Shiomi K, Keino-Masu K, Masu M. Expression of mouse Coiled-coil-DIX1 (Ccd1), a positive regulator of Wnt signaling, during embryonic development. Gene Expr Patterns 2006, 6:325-30.
11. Wang L, Cao XX, Chen Q, Zhu TF, Zhu HG, Zheng L. DIXDC1 targets p21 and cyclin D1 via PI3K pathway activation to promote colon cancer cell proliferation. Cancer Sci 2009, 100:1801-8.
12. Liu T, Wang L, Chen Q, Zheng L, Zhu H. A novel monoclonal antibody specific to DIXDC1 protein. Hybridoma (Larchmt) 2009, 28:183-8.
13. Ghiselli G, Coffee N, Munnery CE, Koratkar R, Siracusa LD. The cohesin SMC3 is a target the for beta-catenin/TCF4 transactivation pathway. J Biol Chem 2003, 278:20259-67.
14. Domazet B, Maclennan GT, Lopez-Beltran A, Montironi R, Cheng L. Laser capture microdissection in the genomic and proteomic era: targeting the genetic basis of cancer. Int J Clin Exp Pathol 2008, 1:475-88.
15. Heath PR, Tomkins J, Ince PG, Shaw PJ. Quantitative assessment of AMPA receptor mRNA in human spinal motor neurons isolated by laser capture microdissection. Neuroreport 2002, 13:1753-7.
16. Lindeman N, Waltregny D, Signoretti S, Loda M. Gene transcript quantitation by real-time RT-PCR in cells selected by immunohistochemistry-laser capture microdissection. Diagn Mol Pathol 2002, 11:187-92.
17. Niida A, Hiroko T, Kasai M. DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin/TCF pathway. Oncogene 2004, 23:8520-6.
18. Guo X, Ramirez A, Waddell DS, Li Z, Liu X, Wang XF. Axin and GSK3- control Smad3 protein stability and modulate TGF- signaling. Genes Dev 2008, 22:106-20.
19. Li M, Chen D, Shiloh A. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 2002, 416:648-53.
20. Hoff H, Zhang H, Sell C. Protein degradation via the proteosome. Methods Mol Biol 2004, 285:79-92.
21. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 1997, 16:3797-804.
22. Peifer M, Polakis P. Wnt signaling in oncogenesis and embryogenesis - a look outside the nucleus. Science 2000, 287:1606-9.
23. van Noort M, Clevers H. TCF transcription factors, mediators of Wnt-signaling in development and cancer. Dev Biol 2002, 244:1-8.
24. Krieghoff E, Behrens J, Mayr B. Nucleo-cytoplasmic distribution of beta-catenin is regulated by retention. J Cell Sci 2006, 119:1453-63.
25. Staal FJ, Noort Mv M, Strous GJ, Clevers HC. Wnt signals are transmitted through N-terminally dephosphorylated beta-catenin. EMBO Rep 2002, 3:63-8.
26. Pickart CM, Eddins MJ. Ubiquitin: structures, functions, mechanisms. Biochim Biophys Acta 2004, 1695:55-72.
27. Ben-Neriah Y. Regulatory functions of ubiquitination in the immune system. Nat Immunol 2002, 3:20-6.
28. Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem 1998, 67:425-79.
29. Liu C, Li Y, Semenov M. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 2002, 108:837-47.